HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

International Cancer Research Conference

March 24-26, 2025 | Singapore

March 24 -26, 2025 | Singapore

Cancer Research 2025

Speaker at International Cancer Research Conference 2025 - Mariola Wioletta Borowska
Oral Presentation (In-Person)
Mariola Wioletta Borowska, Maria Sklodowska-Curie National Research Institute of Oncology, Poland

Hospital care quality and communication with cancer patients is a critical issue in the treatment of this kind of patient. As a chronic, complex illness, cancer treatments and communications with cancer patients need to be more than just providing information. Communication betwe [....] » Read More

Speaker at International Cancer Research Conference 2025 - Changjiang Yang
Oral Presentation (In-Person)
Changjiang Yang, Peking University People's Hospital, China

Recent research has linked Importin7 to cancer aggressiveness and a dismal prognosis, but its function in colorectal cancer (CRC) is unclear. This study aimed to elucidate the clinical relevance, biological function, and potential molecular mechanisms of IPO7 in CRC. Our results [....] » Read More

Speaker at International Cancer Research Conference 2025 - Jian Li
Oral Presentation (In-Person)
Jian Li, Shanghai Jiaotong University, China

Conventional neoadjuvant chemotherapy offers limited benefit for patients with resectable non-small-cell lung cancer (NSCLC). Recently, neoadjuvant chemoimmunotherapy (NCIT) has transformed perioperative management of NSCLC by priming systemic anti-tumor immunity before surgery, [....] » Read More

Speaker at International Cancer Research Conference 2025 - Isah Musa Fakai
Oral Presentation (In-Person)
Isah Musa Fakai, Kebbi State University of Science and Technology, Nigeria

The epidermal growth factor receptor (EGFR) pathway is an important signaling cascade currently investigated for its involvement in cancer therapy. In this study, chalepin isolated from Ruta angustifolia was evaluated for its down regulatory activity on the EGFR signaling cascade [....] » Read More

Speaker at International Cancer Research Conference 2025 - Mariola Wioletta Borowska
Poster Presentation (In-Person)
Mariola Wioletta Borowska, Maria Sklodowska-Curie National Research Institute of Oncology, Poland

The human papillomavirus (HPV) is an established cause of cervical cancer and other HPV-related dise­ases. This study aims to analyze the variation in coverage by HPV vaccination programs – particularly within European Region countries – and explore possible healt [....] » Read More

Speaker at International Cancer Research Conference 2025 - Mariola Wioletta Borowska
Poster Presentation (In-Person)
Mariola Wioletta Borowska, Maria Sklodowska-Curie National Research Institute of Oncology, Poland

Breast cancer is the most common malignant tumor in women in Poland and in the world. It accounts for about 24% of all cancer cases in Polish women. According to the latest report published in November 2022 by the Sarcoma Association for Sarcomas and Melanomas, as many as 39% of [....] » Read More

Speaker at International Cancer Research Conference 2025 - Jian Li
Poster Presentation (In-Person)
Jian Li, Shanghai Jiaotong University, China

Neoadjuvant immunotherapy with anti-programmed death-1 (neo-antiPD1) has revolutionized perioperative treatment for improving the overall survival (OS) of patients with early-stage lung cancer. Despite its transformative impact, neo-antiPD1 provides limited benefit to nearly 50% [....] » Read More

Speaker at International Cancer Research Conference 2025 - Hefdhallah Al-Aizari
Poster Presentation (In-Person)
Hefdhallah Al-Aizari, Ibn Tofail University, Morocco

Participatory and collaborative communication plays a crucial role in territorial governance to find innovative solutions for the proper functioning of public service. This study examines the importance of participatory and collaborative communication in good territorial governan [....] » Read More

Speaker at International Cancer Research Conference 2025 - Davoud Shojaeizadeh
Poster Presentation (In-Person)
Davoud Shojaeizadeh, Tehran University of Medical Sciences, Iran (Islamic Republic of)

Esophageal cancer is one of the most widespread disease in Golestan Province , Iran. To identify risk factors a lot of research has been done. Because health workers have successful experiences of health education. The purpose of this study is to use social marketing to influence [....] » Read More

Speaker at International Cancer Research Conference 2025 - Rajvir Dahiya
Keynote Presentation
Rajvir Dahiya, University of California San Francisco, United States

Background: Current screening methods, have limitations in the diagnosis and prognosis of prostate cancer. This study examined whether mRNA-genomic biomarkers can improve screening and monitoring of prostate cancer. Methods: We identified a panel of 25 prostate cancer-related [....] » Read More

Speaker at International Cancer Research Conference 2025 - Michael Thompson
Keynote Presentation
Michael Thompson, University of Toronto, Canada

Biosensor technology represents an attractive strategy for the detection and monitoring of biomarkers for disease states within the context of precision medicine. This approach offers the possibility for biomarker assay via incorporation into an automated robotic system to proces [....] » Read More

Speaker at International Cancer Research Conference 2025 - Qian Zhang
Oral Presentation (Virtual)
Qian Zhang, The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, China

Autophagy exerts a vital role in lung squamous cell carcinoma (LUSC) progression. Ubiquitin Specific Peptidase 31 (USP31) has recently been found to be involved in the development of a variety of cancers. However, whether USP31 modulates autophagy in LUSC remains uncovered. This [....] » Read More

Speaker at International Cancer Research Conference 2025 - Liling Jiang
Oral Presentation (Virtual)
Liling Jiang, Shapingba District People's Hospital of Chongqing, China

All studies were performed on a 3 T whole-body MRI system (MAGNETOM Prisma, Siemens Healthineers, Erlangen, Germany) using a 16-channel surface coil (Zhongzhi Medical, Jiangsu). Firstly, we evaluated the thyroid nodule image quality between two diffusion weighted imaging (DWI) te [....] » Read More

Speaker at International Cancer Research Conference 2025 - Zheng Wang
Oral Presentation (Virtual)
Zheng Wang, Shanghai Jiao Tong University School of Medicine, China

My topic focus on precision medicine and translational research of breast cancer, including three parts: 1. Homologous recombination repair deficiency in breast cancer; 2. Clinical patterns and predictive models of cancer metastasis; 3. Tumor immunity and the immune microenvironm [....] » Read More

Speaker at International Cancer Research Conference 2025 - Alireza Bahramian
Oral Presentation (Virtual)
Alireza Bahramian, University of Tehran, Iran (Islamic Republic of)

This study introduces a novel thermodynamic marker for cancer diagnosis, revealing a fundamental interrelationship between membrane tension, the aspect ratio of cells during late anaphase, and spindle angle. Central to this discovery is the identification of Inter-Cyto-Tension (I [....] » Read More

Speaker at International Cancer Research Conference 2025 - Nayab Mustansar
Oral Presentation (Virtual)
Nayab Mustansar, Fc Teaching Hospital Peshawar, Pakistan

Neuroendocrine tumours (NETs) of the gallbladder are rare and represent a challenging clinical scenario due to their aggressive nature and late presentation. We report a case of a 60-year-old female diagnosed with a stage 4B neuroendocrine tumour of the gallbladder. This case und [....] » Read More

Speaker at International Cancer Research Conference 2025 - Maurice T. Agonnoude
Oral Presentation (Virtual)
Maurice T. Agonnoude, ENATSE/UP, Benin

Introduction: The integration of breast cancer screening into daily clinical care leads to an early diagnosis and reduces its mortality. However, many women are reluctant and do not get tested. Objective To study the factors associated with the practice of breast cancer scre [....] » Read More

Speaker at International Cancer Research Conference 2025 -  Luiza Simonyan
Oral Presentation (Virtual)
Luiza Simonyan, L. A. Orbeli Institute of Physiology NAS RA, Armenia

Modern medical methods of treatment allow in some cases to prevent the development of pathological processes in the human body. It is known that the effectiveness of such therapeutic effects is largely determined by the possibility of diagnosing the disease at the initial stages [....] » Read More

Will be updated soon......
Watsapp